| Literature DB >> 26767971 |
Nurhanisah Sejari1, Kamaria Kamaruddin1, Kalavathy Ramasamy2,3, Siong Meng Lim2,3, Chin Fen Neoh2,3, Long Chiau Ming4,5.
Abstract
BACKGROUND: The treatment of low back pain is very challenging due to the recurrent nature of the problem. It is believed that traditional Malay massage helps to relieve such back pain but there is a lack of scientific evidence to support both the practice of traditional Malay massage and the mechanism by which it exerts its effect. The aim of this study is to investigate the immediate effect of traditional Malay massage on the pain scale, substance P, inflammatory mediators, and functional outcomes among low back pain patients.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26767971 PMCID: PMC4714433 DOI: 10.1186/s12906-016-0988-1
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Study protocol
Analytical and assessment characteristics
| No. | Assessment | Explanation |
|---|---|---|
| 1. | Blood sample | Blood collection |
| - 10 ml of venous blood will be taken by a trained nurse. | ||
| - The whole blood will be collected into a plain polyethylene tube until blood clot formation. | ||
| - The clots will be separated from the wall of tube using a wooden applicator stick. | ||
| - The serum will be separated by centrifugation at 10,000 g at 4 °C for 15 min to eliminate debris and cellular matter. | ||
| Blood test | ||
| 1) Substance P | ||
| - The blood serum will be tested using Human Substance P EIA kit (Cusabio Biotech) | ||
| 2) Cytokines | ||
| - The blood serum will be tested individually using Elisa kits to investigate | ||
| a) TNF-α | ||
| b) IL-1β | ||
| c) IL-6 | ||
| d) IL-8 | ||
| e) IL-10 | ||
| c) monocyte chemotactic protein-1 (MCP-1) | ||
| d) The soluble form of intercellular adhesion molecule (Sicam-1). | ||
| 2. | Saliva sample | Saliva collection |
| - 3 to 4 ml of unstimulated (resting) whole saliva will be collected 2 min after the patient has rinsed his/hermouth several times with tap water. | ||
| - The accumulated saliva in the floor of the mouth will be drawn by a plastic disposable pipette and collected into a plastic polyethylene tube. | ||
| - The collected saliva will be centrifuged at 10,000 g at 4 °C for 15 min to eliminate debris and cellular matter. | ||
| Blood test | ||
| 1) Substance P | ||
| - The blood serum will be tested using Human Substance P EIA kit (Cusabio Biotech) | ||
| 2) Cytokines | ||
| - The blood serum will be tested individually using Elisa kits to investigate: | ||
| a) TNF-α | ||
| b) IL-1β | ||
| c) IL-6 | ||
| d) IL-8 | ||
| e) IL-10 | ||
| c) monocyte chemotactic protein-1 (MCP-1) | ||
| d) The soluble form of intercellular adhesion molecule (sICAM-1). | ||
| 3. | Visual Analogue Scale (VAS) | - Pain intensity will be measured using VAS by asking the patients to describe their pain level before and after treatment. |
| 4. | Roland-Morris Disability questionnaire | - Functional disability will be measured using the Roland-Morris Disability questionnaire. |